Novartis' Ciba Vision Unit Has Good Results; Alcon Purchase Pending

The consumer health unit of Novartis, which includes CIBA Vision, has reported a 7 percent increase in net sales to $1.5 billion in the second quarter of 2010. The division's European sales were up by 5 percent to $600 million, with the strongest growth in France, the U.K. and Germany. ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.